ABSTRACT Collagen immunofluorescence studies were performed on biopsy specimens from 25 patients with cryptogenic fibrosing alveolitis. We studied the relationship of these results to the clinical, radiological, and physiological assessments of disease activity during six-month periods before and after the lung biopsy; to the appearances on routine histological examination; to the inflammatory cell proportions in bronchoalveolar lavage fluid; and to the response to treatment. Positive associations were observed between the presence of type III collagen and disease activity before (p < 0.015) and after (p < 0.02) lung biopsy. These were independent of clinical and routine histological features. The type-III-positive group also contained nine of the 11 responding to treatment. None of the type-III-positive patients had a quiescent or stable course. In contrast, most patients with no type-III-collagen fluorescence had a stable course over the time of this study and did not improve on treatment. It is suggested that collagen typing may be an additional useful method of assessing potentially reversible disease in cryptogenic fibrosing alveolitis.
Patients fulfilling the clinical criteria for cryptogenic fibrosing alveolitis' form a heterogeneous group in respect of histological features, response to treatment, and rate of progression of disease. The variable survival rate was well illustrated in a recent large, retrospective study.2 Half of the patients had died within 3-2 years of first hospital attendance, but a quarter were still alive after 10 years. Furthermore, the mean survival of untreated patients was longer than that of patients who were treated but failed to respond. 3 In view of this variability, the assessment of activity and potential reversibility of disease becomes important if patients are to be treated at an appropriate time and before irreversible fibrosis has occurred. Clinical, physiological, and radiological data;2 4-8 grading of histological features;2 5 6 inflammatory cell proportions in bronchoalveolar lavage fluid;7- ' and gallium-67-citrate lung scans8 have all been used for this purpose. Combinations of these are useful for determining disease severity, and to a lesser extent for confirming disease activity. Their value in predicting response to treatment has, however, been poor.
Several, but not all, studies have emphasised that corticosteroid responsiveness tends to relate to more cellular and less fibrotic change in lung biopsies,3-1 12 but there are many exceptions and in particular not all patients with cellular disease respond. For example, 10 (38.5%) of 26 cases classified as desquamative interstitial pneumonitis failed to improve on corticosteroids.4 The need for more reliable methods remains.
Several idiotypes of the collagen molecule are found in the lung, each with its distinctive fibril form, functional characteristics, and biological properties. Type I collagen is the most plentiful collagen in normal organs and in scar tissue. During the early phases of fibrosis and scar formation in the lung, however, as in other tissues, the ratio of type III to type I collagen increases temporarily. '3-'5 On the basis of collagen immunofluorescence studies we have suggested that areas of mature collagen in sites of established (and probably irreversible) scar tissue in lung can be distinguished from areas of early active fibrosis, and that this information might be useful in the management of certain lung disorders. ' The H and E section and connective-tissuestained specimens were examined by light microscopy and a four-point score was used to assess alveolar wall fibrosis, alveolar wall thickening, architectural destruction, intra-alveolar cellularity, and cellular infiltrate. In addition, each specimen was graded as "cellular" -abnormal increase in intra-alveolar and interstitial mononuclear cells, with little fibroblast or connective tissue deposition; "fibrotic" -connective tissue accumulation with variable numbers of interstitial fibroblasts but few inflammatory cells; or "mixed" -roughly equal proportions of the above features.
Owing to the subjective nature of these examina-95 tions the following procedures were adopted: (1)All immunofluorescence and light microscopy was done by one observer without knowledge of the patients' clinical details. (2) Indirect immunofluorescence studies were performed on biopsy specimens in six batches, with previously determined optimal dilutions of the single set of reactants being used on each. The appropriate controls '9 for indirect immunofluorescence and a "control tissue" (human fetal lung at 20 weeks' gestation) were included with each batch of lung samples. Six pathological specimens were processed on two different occasions. The same interpretation of fluorescence was made on each, confirming minimal interbatch variation. ( 3) The indirect immunofluorescence and light microscopy studies were performed on separate occasions and repeated several days later.
CLINICAL COURSE AND RESPONSE 10 
TREATMENT
The patients' clinical course was considered in two parts: a period of six months before lung biopsies studied retrospectively, and (in all except those from whom necropsy specimens were obtained) a period of at least six months assessed prospectively after biopsy. All assessments were based on a four-point clinical grading of dyspnoea; measurement of forced vital capacity (FVC); measurement of transfer factor for carbon monoxide (TLCO) by the singlebreath method and estimation of carbon monoxide transfer corrected for volume of ventilated lung (Kco) on the basis of lung volume determined by a helium dilution method; and chest radiographs read by two observers independently using the ILO/ UICC scoring system.20 Plates were read individually in random order and then in pairs to assess change. FVC and Kco were expressed as percentages of values predicted for sex, age, and height2' and only changes of greater than 10% were considered to indicate improvement or deterioration. The clinical assessment was repeated on two or more occasions during the six-month follow-up period.
"Clinical change" was defined as chinge in two of these four parameters, sustained for six months. Initial and follow-up assessments and treatment were supervised by clinicians who did not know the results of the indirect immunofluorescence studies.
Corticosteroid treatment comprised a daily dose of 40-50 mg prednisone (adjusted for age, weight, and sex) given for 4 to 6 weeks. Where improvement was observed a gradual reduction over several months was attempted. When unacceptably high doses were required to maintain improvement, or when no response was observed, other treatments were attempted (table 2) . During the course of this Seven of the nine non-responders to corticosteroids were treated with alternative regimens but none improved. Three patients were not treated with corticosteroids but received either a combination of cyclophosphamide, colchicine, and cyproheptadine (one of two improved) or pencillamine and immunosuppressants (no response).
The terminal events in the six cases in which necropsy specimens were obtained were: ischaemic heart disease (case 19), pulmonary thromboembolism (case 2), Haemophilus septicaemia (case 14), fulminant influenza due to influenza B virus (case 3), herpes simplex (case 12), and measles pneumonia (case 6).
COMPARISON OF PATIENTS POSITIVE AND NEGATIVE FOR TYPE III COLLAGEN
All the patients who were positive for type III collagen (table 2) were deteriorating before biopsy, and continued to show signs of disease activity after biopsy or the start of treatment; there was continued deterioration in five and response to treatment in nine. In contrast, most patients who were negative for type III had a stable course before biopsy, only two showing features of deterioration. Most but not all the treatment responders were positive for type III, the trend not reaching statistical significance (table 3) . Thus a strong positive association was observed between disease activity and the presence of type III collagen in lung biopsy specimens, but not between the latter and treatment response. This association was not accounted for by differences in histological score and there were no significant differences between the groups when analysed for age, sex, presence of crepitations, or the number of 
